These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8585560)

  • 41. Annotation: Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach.
    Cornish KM; Turk J; Wilding J; Sudhalter V; Munir F; Kooy F; Hagerman R
    J Child Psychol Psychiatry; 2004 Sep; 45(6):1042-53. PubMed ID: 15257661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
    Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
    In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Who should be tested for fragile X carriership? A review of 1 center's pedigrees.
    Rajendra K; Bringman JJ; Ward J; Phillips OP
    Am J Obstet Gynecol; 2008 May; 198(5):e51-3. PubMed ID: 18358452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
    Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
    J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular markers of fragile X: application to males at risk in fragile X families.
    Brown WT; Goonewardena P; Gross AC; Dobkin C; Jenkins EC
    Prog Clin Biol Res; 1991; 368():73-7. PubMed ID: 1946507
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of fragile X on physical and intellectual traits estimated by pedigree analysis.
    Loesch DZ; Huggins RM; Chin WF
    Am J Med Genet; 1993 Jun; 46(4):415-22. PubMed ID: 8357014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fragile X syndrome.
    Wiebe E; Wiebe A
    Can Fam Physician; 1994 Feb; 40():290-5. PubMed ID: 8130676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fragile X screening: what is the real issue?
    Laxova R
    Am J Med Genet; 1995 Jul; 57(3):508-9. PubMed ID: 7677165
    [No Abstract]   [Full Text] [Related]  

  • 50. Fragile X syndrome.
    Phillips JP; Wilson GA
    Indian J Pediatr; 1998; 65(2):181-91. PubMed ID: 10771963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.
    Lieberman S; Zuckerman S; Levy-Lahad E; Altarescu G
    Am J Med Genet A; 2011 Sep; 155A(9):2154-60. PubMed ID: 21834046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seventh International Workshop on the Fragile X and X-linked Mental Retardation.
    Tranebjaerg L; Lubs HA; Borghgraef M; Brown WT; Fisch G; Fryns JP; Hagerman R; Jacobs PA; Mandel JL; Mulley J; Oostra B; Schwartz C; Sherman S; Willard H; Willems P
    Am J Med Genet; 1996 Jul; 64(1):1-14. PubMed ID: 8826442
    [No Abstract]   [Full Text] [Related]  

  • 53. Fragile X Syndrome: A Review for General Pediatricians.
    Mendez A; Mendez M
    Pediatr Ann; 2024 Jul; 53(7):e269-e271. PubMed ID: 38949875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Problems posed by genetic diseases, concerning DNA instability disorders: fragile X syndrome].
    Lesca G; Curie A; Rousselle C
    Rev Prat; 2010 Feb; 60(2):243-4. PubMed ID: 20225567
    [No Abstract]   [Full Text] [Related]  

  • 55. Genetic epidemiology of the fragile X syndrome with special reference to genetic counseling.
    Sherman SL
    Prog Clin Biol Res; 1991; 368():79-99. PubMed ID: 1946508
    [No Abstract]   [Full Text] [Related]  

  • 56. The impact of genetic counselling on females in fragile X families.
    Curtis G; Dennis N; MacPherson J
    J Med Genet; 1994 Dec; 31(12):950-2. PubMed ID: 7891377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When to tell and test for genetic carrier status: perspectives of adolescents and young adults from fragile X families.
    Wehbe RM; Spiridigliozzi GA; Heise EM; Dawson DV; McConkie-Rosell A
    Am J Med Genet A; 2009 Jun; 149A(6):1190-9. PubMed ID: 19449413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic Testing Practices of Genetic Counselors, Geneticists, and Pediatric Neurologists With Regard to Childhood-Onset Neurogenetic Conditions.
    Wofford S; Noblin S; Davis JM; Farach LS; Hashmi SS; Mancias P; Wagner VF
    J Child Neurol; 2019 Mar; 34(4):177-183. PubMed ID: 30608006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rebuilding my fortress.
    Anonymous
    J Genet Couns; 2012 Apr; 21(2):167-8. PubMed ID: 22160557
    [No Abstract]   [Full Text] [Related]  

  • 60. Carrier testing in fragile X syndrome: effect on self-concept.
    McConkie-Rosell A; Spiridigliozzi GA; Sullivan JA; Dawson DV; Lachiewicz AM
    Am J Med Genet; 2000 Jun; 92(5):336-42. PubMed ID: 10861663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.